Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

INAB IN8bio Inc

1,22

0,19 (18,45%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

IN8bio (NASDAQ:INAB)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more IN8bio Charts.

IN8bio (NASDAQ:INAB)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more IN8bio Charts.

News IN8bio Inc

IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
Freitag 24 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting
Donnerstag 23 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
Dienstag 14 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024
Montag 13 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Donnerstag 9 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Dienstag 7 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
Dienstag 30 April 2024 (1 Monat vor) • GlobeNewswire Inc.

IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Mittwoch 24 April 2024 (1 Monat vor) • GlobeNewswire Inc.

IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Dienstag 16 April 2024 (2 Monate vor) • GlobeNewswire Inc.

IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
Dienstag 9 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere IN8bio Inc News-Artikel

Bank of Montreal Capped ...

Ayalaland Logistics (CE)

ProShares UltraShort MSC...

Wrapped LUNA Token

NLBNPIT207I9 20991231 24...

KardiaChain Token

Hsbc Bank Usa Na Dual Di...

Exchange Income (PK)

NSL Consolidated

IledeFrance Mobilites Id...

Great Divide Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen